Dose Escalation and Expansion Study of CM313 in Subjects With Relapsed or Refractory Multiple Myeloma and Lymphoma
Clinical trial NCT04818372 · UNKNOWN
Trial details
- NCT number
- NCT04818372
- Sponsor
- Keymed Biosciences Co.Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-26
- Primary completion
- 2023-01-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.